Bell Robert G. 13D and 13G filings for ARS Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-09-01 4:15 pm Sale | 2023-08-29 | 13D | ARS Pharmaceuticals, Inc. SPRY | Bell Robert G. | 4,313,965 4.500% | -4,250,000 (-49.63%) | Filing |
| 2022-11-21 4:07 pm Purchase | 2022-11-08 | 13D | ARS Pharmaceuticals, Inc. SPRY | Bell Robert G. | 8,563,965 9.100% | 8,563,965 (New Position) | Filing |